Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Boiron

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Cytotherapy|December 3, 2014
Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphismFontanet Bijou, Zoran Ivanovic, Dominique Fizet, et al.
Experimental Hematology|April 21, 2009
Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivoMarija Vlaski, Xavier Lafarge, Jean Chevaleyre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Reversible myelofibrosis induced by tuberculosisJean-François Viallard, Marie Parrens, Jean-Michel Boiron, et al.
Cell Transplantation|April 4, 2012
Definitive setup of clinical scale procedure for ex vivo expansion of cord blood hematopoietic cells for transplantationPascale Duchez, Jean Chevaleyre, Marija Vlaski, et al.
Cell Transplantation|October 10, 2012
Functional stability (at +4°C) of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cellsPascale Duchez, Jean Chevaleyre, Philippe Brunet de la Grange, et al.
New Biotechnology|October 20, 2011
High hydrostatic pressure treatment for the inactivation of Staphylococcus aureus in human blood plasmaNolwennig Rivalain, Jean Roquain, Jean-Michel Boiron, et al.
Transfusion|December 12, 2012
Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cellsPascale Duchez, Jean Chevaleyre, Philippe Brunet de la Grange, et al.
Transfusion|August 26, 2010
Thrombopoietin to replace megakaryocyte-derived growth factor: impact on stem and progenitor cells during ex vivo expansion of CD34+ cells mobilized in peripheral bloodPascale Duchez, Jean Chevaleyre, Marija Vlaski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosisJean-François Viallard, Marie Parrens, Olivier Hermine, et al.
Cell Transplantation|February 8, 2011
Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activityZoran Ivanovic, Pascale Duchez, Jean Chevaleyre, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Cytotherapy|December 3, 2014
Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphismFontanet Bijou, Zoran Ivanovic, Dominique Fizet, et al.
Experimental Hematology|April 21, 2009
Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivoMarija Vlaski, Xavier Lafarge, Jean Chevaleyre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Reversible myelofibrosis induced by tuberculosisJean-François Viallard, Marie Parrens, Jean-Michel Boiron, et al.
Cell Transplantation|April 4, 2012
Definitive setup of clinical scale procedure for ex vivo expansion of cord blood hematopoietic cells for transplantationPascale Duchez, Jean Chevaleyre, Marija Vlaski, et al.
Cell Transplantation|October 10, 2012
Functional stability (at +4°C) of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cellsPascale Duchez, Jean Chevaleyre, Philippe Brunet de la Grange, et al.
New Biotechnology|October 20, 2011
High hydrostatic pressure treatment for the inactivation of Staphylococcus aureus in human blood plasmaNolwennig Rivalain, Jean Roquain, Jean-Michel Boiron, et al.
Transfusion|December 12, 2012
Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cellsPascale Duchez, Jean Chevaleyre, Philippe Brunet de la Grange, et al.
Transfusion|August 26, 2010
Thrombopoietin to replace megakaryocyte-derived growth factor: impact on stem and progenitor cells during ex vivo expansion of CD34+ cells mobilized in peripheral bloodPascale Duchez, Jean Chevaleyre, Marija Vlaski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosisJean-François Viallard, Marie Parrens, Olivier Hermine, et al.
Cell Transplantation|February 8, 2011
Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activityZoran Ivanovic, Pascale Duchez, Jean Chevaleyre, et al.
Pageof 5